Follow The Filings

SMG Scotts Miracle-Gro Co.

Materials, filed as SCOTTS MIRACLE-GRO CO (CL A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2, sold by 2

  • 2 Owners
  • Max 1.0%
  • $102M
  • 1 new 1 add 1 exit

In 2026 Q2 Farallon Capital Management opened a position in Scotts Miracle-Gro, John Rogers added, and First Pacific Advisors sold out.

Who owns this now

Largest portfolio weights among holders, up to 1.0% (John Rogers, Ariel Investments). Not free-float ownership.

  1. John Rogers Add 0.96%
  2. Farallon Capital Management New 0.03%

Who owns SMG

Sorted by value, long equity only, as of 2026 Q2.

History
John Rogers, Ariel Investments 0.96%, was 0.66% Add +46.6% 1,410,981 $96M History
Farallon Capital Management 0.03% New 0.03% 88,000 $6M History
First Pacific Advisors exited 2026 Q2 Last 2026 Q1 0.01% Exit −0.01% 7,357 $447K History

2 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by SMG's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SMG insider trades
  • $50K bought by 1 insider
  • $5.5M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Mark D Kingdon Director
    Sale
    $51K 831 shares at $61.65 7.1% of stake
    Traded Aug 10 Filed Aug 11
    ↗
  2. Hagedorn Partnership, L.P. Director
    Sale
    $2M 30,000 shares at $67.45 0.2% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  3. Stephen L Johnson Director
    Sale
    $80K 1,171 shares at $68.32 3.7% of stake
    Traded Jul 30 Filed Jul 31
    ↗
  4. Mark J Scheiwer CFO
    Buy
    $50K 693 shares at $71.44 +4.7% to stake
    Traded Feb 24 Filed Feb 25
    ↗
  5. Hagedorn Partnership, L.P. Director
    Sale
    $3.3M 50,000 shares at $66.40 0.4% of stake
    Traded Feb 12 Filed Feb 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 35 other transactions, 29 stock grants, 14 share withholdings for taxes, and 12 option exercises.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K/A 5.02 Filing Doc
8-K 1.02,8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.02 Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.55B $3.55B $3.41B
Gross profit $0.657B $0.85B $1.04B
Gross margin * 18.5% 23.9% 30.6%
Net income -$380.1M -$34.9M $145.2M
Net margin * -10.7% -1.0% 4.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.4B $0.98B $0.94B
Total non-current assets * $2.02B $1.89B $1.8B
Total assets $3.41B $2.87B $2.74B
Total current liabilities $773.7M $750.3M $739.7M
Total non-current liabilities * $2.91B $2.51B $2.36B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $531M $667.5M $371.3M
Cash from investing -$65.7M -$100.4M -$112.1M
Cash from financing -$520.1M -$527.9M -$294M
Net change in cash -$54.9M $39.7M -$35M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.